OCALA, Fla., Nov. 16, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) announces financial results for the third…
VASCEPA/VAZKEPA found in prespecified and post hoc analyses to reduce total ischemic events by 32% in patients with prior PADDUBLIN,…
Net Income Up 137%, EBITDA up 136% Year Over Year. Gross Margins Jump to 30% as Third-Party Services and Testing…
Company is Scheduled to Conduct Pre-IND Meeting with the U.S. FDA Later This Month and Potentially Initiate Phase 1/2 Clinical Trial of…
Third Quarter Revenues of $6.4 Million; Year-to-Date 2021 Revenues Increased 21% Clarity on Regulatory Pathway for Resubmission of NexoBrid BLA,…
The largest and most important Psychedelic Medicine Conference in the Southern HemisphereVancouver, British Columbia--(Newsfile Corp. - November 16, 2021) -…
Toronto, Ontario--(Newsfile Corp. - November 16, 2021) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the…
With a Focus on Bringing the KARE Phase II a/b Trial (Ketamine-Assisted Psychotherapy for Alcohol Use Disorder) into Phase IIIToronto,…
This transaction strengthens Alira Health’s commitment to humanize healthcare FRAMINGHAM, Mass.--(BUSINESS WIRE)--#ai--Alira Health (http://www.alirahealth.com/), a global health care consultancy, announced…
Building on Prophecy’s Legacy of Success, New System Offers Surgeons Fewer Steps, More Efficiency MAHWAH, N.J.--(BUSINESS WIRE)--Stryker today launched the…